|
Preliminary analysis of a phase II, multicenter, randomized, active-control study to evaluate the efficacy and safety of eganelisib (IPI 549) in combination with nivolumab compared to nivolumab monotherapy in patients with advanced urothelial carcinoma. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; EUSA Pharma |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
Elena Sevillano Fernandez |
Honoraria - Bristol-Myers Squibb; MSD; Pfizer; Roche |
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Sanofi |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); MSD (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Pfizer; Roche |
|
|
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck; Novartis |
Research Funding - AstraZeneca (Inst); PharmaMar |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; MERCK; tesaro |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Pfizer |
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Merck Serono; MSD Oncology; Pfizer |
|
|
Employment - Infinity Pharmaceuticals |
Stock and Other Ownership Interests - Infinity Pharmaceuticals |
|
|
Employment - Compass Therapeutics; Infinity Pharmaceuticals |
Stock and Other Ownership Interests - Compass Therapeutics; Infinity Pharmaceuticals |
Travel, Accommodations, Expenses - Compass Therapeutics |
|
|
Employment - Infinity Pharmaceuticals |
Stock and Other Ownership Interests - Infinity Pharmaceuticals |
|
|
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pierre Fabre; Roche |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche |